![Konstantin Konstantinov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Konstantin Konstantinov
Direktor/Vorstandsmitglied bei REPLIGEN CORPORATION
Vermögen: 289 937 $ am 31.08.2024
Ursprung des Netzwerks ersten Grades von Konstantin Konstantinov
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering, Inc. (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.
171
| Private Company | Investment Managers | 171 |
| Public Company | Pharmaceuticals: Major | 27 | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Konstantin Konstantinov
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Director/Board Member Corporate Officer/Principal Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Founder Founder Director/Board Member Founder Chief Executive Officer President | |
Montai Health, Inc.
 Montai Health, Inc. Packaged SoftwareTechnology Services Montai Health, Inc. is a company based in Cambridge, MA. Montai Health, Inc. is unlocking the power of nature with its pioneering AI-powered Conecta™ platform to develop Anthromolecule™ medicines that treat and preempt chronic diseases. The company's platform utilizes hyper-efficient, generalizable ML and the aggregation of Anthromolecule chemistry at an industry-first scale to discover precision-matched, human-qualified chemistry that engages validated biological pathways. Montai Health is rapidly advancing a pipeline of first-in-class or small-molecule assets against multiple powerful, validated biological pathways in inflammation and autoimmune diseases. The company was founded by David Kolesky, Hok Hei Tam, Mary Margaret Hastings Georgiadis, and Michael Wong, with Mary Margaret Hastings Georgiadis serving as the CEO since 2022. | Packaged Software | Founder Director/Board Member Director/Board Member Founder Chief Operating Officer | |
CiBO Technologies, Inc.
 CiBO Technologies, Inc. Packaged SoftwareTechnology Services CiBO Technologies, Inc. is a science-driven software company which engage sin the modelling and simulation of agricultural ecosystems. The firm offers CIBO and CIBO Plus software products. The company was founded by Ignacio Bemposta Martinez and Bruno Basso in 2015 and is headquartered in Cambridge, MA. | Packaged Software | Director/Board Member Director/Board Member Founder Chairman Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Chairman Director/Board Member | |
Inari Agriculture, Inc.
 Inari Agriculture, Inc. BiotechnologyHealth Technology Inari Agriculture, Inc. engages biotechnology research and development. It specializes in plant breeding technology. The company was founded by David Berry, Ignacio Martinez, George Church, and Steve Jacobsen in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Founder Founder Director/Board Member Director/Board Member | |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Founder Chief Executive Officer Chairman President | |
| AXCA HEALPAR | Biotechnology | Founder Director/Board Member Director of Finance/CFO Director/Board Member Chairman | |
Invaio Sciences, Inc.
 Invaio Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Invaio Sciences, Inc. operates as multi-platform technology company. The firm develops multi-platform technology company that unlocks the potential of planet's interdependent natural systems to solve pressing agriculture, nutrition and environmental challenges. The company was founded in 2018 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer Founder Founder Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
Alltrna
 Alltrna BiotechnologyHealth Technology Alltrna is a company based in Cambridge, MA that focuses on deciphering trna biology and developing trna therapeutics to treat various diseases. The company's platform utilizes AI/ML tools to create programmable molecules with extensive therapeutic potential. Alltrna aims to advance a single trna medicine that can readthrough premature stop codons and provide unified treatment for different diseases with similar genetic mutations. Alltrna was founded in 2018 by Flagship Pioneering, and Lovisa Afzelius has been the CEO since its inception. | Biotechnology | Founder Director/Board Member Chief Executive Officer Founder | |
Abiologicsb LLC
 Abiologicsb LLC BiotechnologyHealth Technology AbiologicsB LLC provides consulting services. The company is based in Greater Boston, MA. The company was founded by Avak Kahvejian, and Avak Kahvejian has been the CEO since incorporation. | Biotechnology | Founder Chief Executive Officer Founder Founder | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Ampersand Biomedicines, Inc. is a company that specializes in developing smarter biologic medicines. The company is based in Boston, MA and has subsidiaries in Czechia and the United States. The company's state-of-the-art computationally powered platform allows them to design therapeutics that effectively target the site of disease without affecting healthy tissue or cells. Ampersand Biomedicines enables a new way of programming medicines that work precisely where needed in the body and nowhere else. The company has a systematic approach to identifying localized targets in healthy and diseased tissues, allowing them to navigate a large range of diseases in almost all areas of the body. The company was founded in 2020 by Avak Kahvejian, Noubar B. Afeyan, and Raffi Afeyan. Jason Gardner has been the CEO of the company since 2023. | Biotechnology | Founder Founder Chief Executive Officer Founder | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member Founder | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| New York University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Profound Therapeutics
 Profound Therapeutics Pharmaceuticals: OtherHealth Technology Profound Therapeutics is a company that is focused on discovering new medicines by expanding the human proteome. The company is based in Cambridge, MA. The company uses their platform, Profoundry, to identify and validate proteins and understand their therapeutic potential. This results in a growing database of novel proteins and their roles in health and disease. The company was founded in 2020 by Avak Kahvejian, who has been the CEO since then. | Pharmaceuticals: Other | Chairman Chief Executive Officer President | |
| University of California, Berkeley | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Founder Director/Board Member Chairman | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Founder Chief Administrative Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| BG MEDICINE, INC. | Medical Specialties | Founder Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MODERNA, INC. | Biotechnology | Director/Board Member Founder Director/Board Member | |
Inzen Therapeutics, Inc.
 Inzen Therapeutics, Inc. BiotechnologyHealth Technology Part of Sonata Therapeutics, Inc., Inzen Therapeutics, Inc. is discovering and developing a novel class of medicines based on thanokine biology. The company is based in Cambridge, MA. Thanokine biology offers the potential for unprecedented approaches to prevent and treat cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders, and degenerative diseases. Inzen's thanokine product platform applies advances in mass spectrometry and machine learning, novel probes, unique assays, genetic and chemical biological technologies to characterize thanokine biology at scale and create drug candidates. Inzen Therapeutics harnesses signals of the cellular microenvironment to treat serious diseases. The company was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability. | Biotechnology | Director/Board Member Director/Board Member President | |
| THERMO FISHER SCIENTIFIC INC. | Medical Specialties | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Founder Chairman Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| RUBIUS THERAPEUTICS | Biotechnology | Founder Director/Board Member Founder | |
Harbinger Health
 Harbinger Health Information Technology ServicesTechnology Services Harbinger Health, Inc. is a company based in Cambridge, MA. Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. The company combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test. Harbinger envisions a future where cancer could be kept from forming, making a cancer diagnosis a routine health problem to be addressed rather than a life-altering event to be feared with profound implications for people, healthcare systems, and societies. The company fundamentally transforms cancer care for everyone. The company was founded in 2020 by Alexander Meissner, Sidney Farber, Zachary Smith, Franziska Michor. The CEO is Stephen Hahn. | Information Technology Services | Director/Board Member Director/Board Member | |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Midori USA, Inc.
 Midori USA, Inc. Miscellaneous Commercial ServicesCommercial Services Midori USA, Inc. develops cellulosic technology for conversion of biomass to fuels. It offers biomass barrier technology that melts and digests biomass into sugars with a solid, recyclable catalyst. The company was founded by J. M. Geremia and Brian Baynes in 2008 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Doctorate Degree | |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Biotechnology | Founder Founder | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 49 |
| Vereinigtes Königreich | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 13 |
| Commercial Services | 8 |
| Technology Services | 4 |
| Finance | 2 |
Operativ
| Director/Board Member | 289 |
| Corporate Officer/Principal | 122 |
| Founder | 105 |
| Private Equity Investor | 75 |
| Undergraduate Degree | 75 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Noubar Afeyan | 77 |
| George Church | 45 |
| Margo Georgiadis | 34 |
| Ed Kania | 31 |
| Michael Rosenblatt | 31 |
| Martin Madaus | 30 |
| Theo Melas-Kyriazi | 26 |
| Karen Dawes | 22 |
| Ignacio Martinez | 21 |
| Nicolas Barthelemy | 19 |
| Christian Schade | 18 |
| Glenn Muir | 18 |
| Stefan Strein | 15 |
| Avak Kahvejian | 14 |
| Diego Miralles | 14 |
- Börse
- Insiders
- Konstantin Konstantinov
- Unternehmensverbindungen
